Author:
Yoo Hae Young,Zheng Haifeng,Nam Joo Hyun,Nguyen Yen Hoang,Kang Tong Mook,Earm Yung E.,Kim Sung Joon
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Clinical Biochemistry,Physiology
Reference35 articles.
1. Amigorena S, Choquet D, Teillaud J-L, Korn H, Fridman WH (1990) Ion channel blockers inhibit B cell activation at a precise stage of the G1 phase of the cell cycle. J Immunol 144:2038–2045
2. Begenisich T, Nakamoto T, Ovitt CE, Nehrke K, Brugnara C, Alper SL, Melvin JE (2004) Physiological roles of the intermediate conductance Ca2+-activated potassium channel KCNN4. J Biol Chem 279:47681–47687
3. Bezprozvanny I, Tsien RW (1995) Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967). Mol Pharmacol 48:540–549
4. Blaheta RA, Hailer NP, Brude N, Wittig B, Oppermann E, Leckel K, Harder S, Scholz M, Weber S, Encke A, Markus BH (1998) Novel mode of action of the calcium antagonist mibefradil (Ro40-5967): potent immunosuppression by inhibition of T-cell infiltration through allogeneic endothelium. Immunology 94:213–220
5. Boulanger CM, Nakashima M, Olmos L, Joly G, Vanhoutte PM (1994) Effects of the Ca2+ antagonist RO 40-5967 on endothelium dependent responses of isolated arteries. J Cardiovasc Pharmacol 23:869–876
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献